Johansson L, Lefèvre J P, Kowalski A. "Method for the Synthesis of Ibrutinib Impurity 91" [P]. European Patent, EP 3641438 A1, 2023-01-10.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质91 in Pharmaceutical Formulations". Anal. Methods, 2013, 1628, (11), 553-556.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质91 as an Impurity". J. Chromatogr. A, 2025, 2135, (6), 4195-4212.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 91 Using HRMS and NMR". Anal. Chem., 2022, 527, (10), 4688-4708.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 伊布替尼杂质91 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2018, 455, (4), 3106-3115.